Overview
Martin Spacek practices in Prague, Czech Republic. Mr. Spacek is rated as a Distinguished expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and Leukemia.
His clinical research consists of co-authoring 29 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 19 articles and participated in 1 clinical trial in the study of Chronic B-Cell Leukemia (CBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Mr. Spacek isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Spacek isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Advanced
- LeukemiaMr. Spacek isAdvanced. Learn about Leukemia.
- Small Lymphocytic Lymphoma (SLL)Mr. Spacek isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- Experienced
- COVID-19Mr. Spacek isExperienced. Learn about COVID-19.
- Lymphofollicular HyperplasiaMr. Spacek isExperienced. Learn about Lymphofollicular Hyperplasia.
- Severe Acute Respiratory Syndrome (SARS)